This Report provides an analytical description of the use of medicines, in the national and regional context, during 2022, through the elaboration of various information flows that allow to obtain a comprehensive picture of pharmaceutical care in the local and hospital settings, both borne by the National Health Service (SSN) and through private purchases by the citizen.

OsMed flows have been used for analysing consumption under the approved care regime, whereas the medicine traceability flows have been used to analyse the consumption of medicines purchased by health facilities.

In addition, for analysing prescriptions by age and gender and exposure and for estimating adherence and persistence, data from all Italian Regions, collected through the information flow of pharmaceutical prescriptions reimbursed by the NHS (Tessera Sanitaria) have been analysed.

For assessing purchases by citizens, data collected through the Medicine Traceability flow for medicinal products delivered to public and private local pharmacies have been used.

Finally, regional flows were used to analyse expenditure and consumption of medicines delivered through direct distribution and distribution in name and “on behalf”.

Published on: 01 December 2023